13 research outputs found
Acute amnestic encephalopathy in amyloid-beta oligomer-injected mice is due to their widespread diffusion in vivo
International audienceAmyloid-beta (A beta) oligomers are the suspected culprit as initiators of Alzheimer's disease (AD). However, their diffusion in the brain remains unknown. Here, we studied A beta oligomers' dissemination and evaluated their in vivo toxicity. Wild-type mice were injected with 50 pmol of synthetic A beta oligomers (of different size) in the hippocampus. Oligomers diffused largely in the brain as soon as 1 hour and up to 7 days after injection. A transient encephalopathy with memory impairment was induced by this unique injection. The immunoreactivity of the postsynaptic marker PSD95 was diffusely decreased. Similar results (both on memory and PSD95 immunoreactivity) were obtained with delipidated and high molecular weight oligomers (>50 kDa) but not with smaller assemblies. Tau hyperphosphorylation was observed in the oligomer-injected brains. Finally, fos immunostaining was increased in A beta-derived diffusible ligandseinjected mice, suggesting neuronal hyperactivity. Rapid and widespread diffusion of Ab oligomers was demonstrated in vivo and associated with decreased synaptic markers and memory deficits which gives new insight to the pathogenicity of A beta
Alzheimer’s Disease Pathology in the Neocortex and Hippocampus of the Western Lowland Gorilla (Gorilla Gorilla Gorilla)
The two major histopathologic hallmarks of Alzheimer\u27s disease (AD) are amyloid beta protein (Aβ) plaques and neurofibrillary tangles (NFT). Aβ pathology is a common feature in the aged nonhuman primate brain, whereas NFT are found almost exclusively in humans. Few studies have examined AD-related pathology in great apes, which are the closest phylogenetic relatives of humans. In the present study, we examined Aβ and tau-like lesions in the neocortex and hippocampus of aged male and female western lowland gorillas using immunohistochemistry and histochemistry. Analysis revealed an age-related increase in Aβ-immunoreactive plaques and vasculature in the gorilla brain. Aβ plaques were more abundant in the neocortex and hippocampus of females, whereas Aβ-positive blood vessels were more widespread in male gorillas. Plaques were also Aβ40-, Aβ42-, and Aβ oligomer-immunoreactive, but only weakly thioflavine S- or 6-CN-PiB-positive in both sexes, indicative of the less fibrillar (diffuse) nature of Aβ plaques in gorillas. Although phosphorylated neurofilament immunostaining revealed a few dystrophic neurites and neurons, choline acetyltransferase-immunoreactive fibers were not dystrophic. Neurons stained for the tau marker Alz50 were found in the neocortex and hippocampus of gorillas at all ages. Occasional Alz50-, MC1-, and AT8-immunoreactive astrocyte and oligodendrocyte coiled bodies and neuritic clusters were seen in the neocortex and hippocampus of the oldest gorillas. This study demonstrates the spontaneous presence of both Aβ plaques and tau-like lesions in the neocortex and hippocampus in old male and female western lowland gorillas, placing this species at relevance in the context of AD research.</p
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Synapse-Binding Subpopulations of Aβ Oligomers Sensitive to Peptide Assembly Blockers and scFv Antibodies
Amyloid β42 self-assembly is complex, with multiple
pathways
leading to large insoluble fibrils or soluble oligomers. Oligomers
are now regarded as most germane to Alzheimer’s pathogenesis.
We have investigated the hypothesis that oligomer formation itself
occurs through alternative pathways, with some leading to synapse-binding
toxins. Immediately after adding synthetic peptide to buffer, solutions
of Aβ42 were separated by a 50 kDa filter and fractions assessed
by SDS-PAGE silver stain, Western blot, immunoprecipitation, and capacity
for synaptic binding. Aβ42 rapidly assembled into aqueous-stable
oligomers, with similar protein abundance in small (<50 kDa) and
large (>50 kDa) oligomer fractions. Initially, both fractions were
SDS-labile and resolved into tetramers, trimers, and monomers by SDS-PAGE.
Upon continued incubation, the larger oligomers developed a small
population of SDS-stable 10–16mers, and the smaller oligomers
generated gel-impermeant complexes. The two fractions associated differently
with neurons, with prominent synaptic binding limited to larger oligomers.
Even within the family of larger oligomers, synaptic binding was associated
with only a subset of these species, as a new scFv antibody (NUsc1)
immunoprecipitated only a small portion of the oligomers while eliminating
synaptic binding. Interestingly, low doses of the peptide KLVFFA blocked
assembly of the 10–16mers, and this result was associated with
loss of the smaller clusters of oligomers observed at synaptic sites.
What distinguishes these smaller clusters from the unaffected larger
clusters is not yet known. Results indicate that distinct species
of Aβ oligomers are generated by alternative assembly pathways
and that synapse-binding subpopulations of Aβ oligomers could
be specifically targeted for Alzheimer’s therapeutics